DRI officials seize 119.4 kg of Alprazolam worth Rs. 23.88 crore

New Delhi:  The officers of Directorate of Revenue Intelligence from Hyderabad, Visakhapatnam, Vijayawada and Kakinada executed a swift and well-coordinated operation resulting in seizure of 119.4 kg Alprazolam in lumpy form, valued at approximately Rs. 23.88 crore in the illicit market, along with 87.8 kg in-process material. The DRI officials also apprehended eight persons involved in illegal manufacturing and distribution of Alprazolam, including the master-mind, chemists, financiers and the buyers at the same place.

After developing a specific intelligence that a few persons were clandestinely manufacturing ‘Alprazolam’ — a psychotropic substance under the NDPS Act, 1985 — at a facility in Atchutapuram, Anakapalli District, Andhra Pradesh, the DRI officials meticulously planned the operation to arrest the entire set of persons involved in manufacturing and distribution of Alprazolam.

Additionally, 3,600 litres in liquid form and 311.6 kg in solid form of illegally procured raw materials, equipment (two reactors, one centrifuge and one drier) used for manufacturing Alprazolam and few incriminating documents were seized to aid further investigation.

All the eight accused persons were arrested and remanded to judicial custody. It is noteworthy that most of the arrested individuals have prior involvement in cases related to the clandestine manufacture of narcotic drugs and psychotropic substances and other criminal activities (murder, cyber-crimes and economic offences).

Initial interrogation revealed that these individuals conspired to undertake this illegal activity, having formed their network during their time in jail, underscoring the deep-rooted and organized nature of the syndicate. The said Alprazolam was intended for transport to Telangana for adulterating Toddy.

Further investigation in the case is in progress.

Related Posts

NHS backs delayed‑release treatment for cystinosis

Decision expands options for eligible patients NHS England has recommended delayed‑release mercaptamine bitartrate for routine commissioning for eligible patients aged one year and above with nephropathic cystinosis. The decision provides…

Maharashtra FDA Permanently Cancels Licence of Pune Ayurvedic Drug Manufacturer Over Serious GMP and Quality Violations

Mumbai/Pune: In a major regulatory enforcement action aimed at safeguarding public health, the Maharashtra Food and Drug Administration (FDA) has permanently cancelled the Ayurvedic drug manufacturing licence of Pune-based M/s Inducare Pharma…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

NHS backs delayed‑release treatment for cystinosis

NHS backs delayed‑release treatment for cystinosis

Promotion of Drug Inspectors (Medical Devices) raises hopes of Effective Regulation & Patient Safety

Promotion of Drug Inspectors (Medical Devices) raises hopes of Effective Regulation & Patient Safety

Maharashtra FDA Permanently Cancels Licence of Pune Ayurvedic Drug Manufacturer Over Serious GMP and Quality Violations

Maharashtra FDA Permanently Cancels Licence of Pune Ayurvedic Drug Manufacturer Over Serious GMP and Quality Violations

Telangana DCA Seizes Gabapentin Tablets Falsely Sold as Nutraceuticals in Hyderabad

Telangana DCA Seizes Gabapentin Tablets Falsely Sold as Nutraceuticals in Hyderabad

Massive Blood Wastage in Gujarat: Over 85,000 Units Discarded Due to Storage Lapses and Expiry

Massive Blood Wastage in Gujarat: Over 85,000 Units Discarded Due to Storage Lapses and Expiry

AmeriHealth Home Healthcare Celebrates 5 Years of Compassionate Care

AmeriHealth Home Healthcare Celebrates 5 Years of Compassionate Care